Peripheral artery disease of the lower limbs and morbidity/mortality in type 2 diabetics;Arteriopatía periférica de extremidades inferiores y morbimortalidad en pacientes diabéticos tipo 2

Atencion Primaria

Volumn 38, Issue 3, 2006, Pages 139-144

  Bundó Vidiella, Magdalena ^a,c   Pérez Pérez, Carmen ^a   Montero Alia, Juan José ^a   Cobos Solórzano, María Dolores ^a   Aubà Llambrich, Josep ^a   Cabezas Peña, Carmen ^b  

^a Centro de Salud Ronda Prim   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c Centro de Salud Ronda Prim   (Spain)

Author keywords

Ankle brachial index; Cardiovascular disease; Peripheral artery disease; Type 2 diabetes mellitus

Indexed keywords

ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HEART FAILURE; HUMAN; LEG; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 33748762251     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13090972     Document Type: Article

References (32)

1. Kannel WB, Skinner JJ, Schwartz MJ, Shuerleff D. Intermittent claudication. Incidence in the Framingham study. Circulation. 1970;XLI:875-83.
2. Criqui M, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
3. Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure index and mortality in eldery women. JAMA. 1993;270:465-9.
4. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996;313:1440-4.
5. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg. 1969;56:676-701.
6. Prineas RJ, Chairman PD, Harland WR, Janzon L, Kannel W. Recomendations for use non-invasive methods to detect aterosclerotic peripheral arterial disease in population studies. American Heart Association Council on Epidemiology. Circulation. 1982;65:A1562-5.
7. Ouriel K, Mc Donnell AE, Metz CE, Zarins CK. A critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982;91:686-93.
8. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-28.
9. Hooi JD, Kester AD, Stoffers HE, Rinkens PE, Knottnerus JA, Van Ree JW. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol. 2004;57:294-300.
10. Hiatt AJJ. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608-21.
11. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vascular Med. 1997;2:221-6.
12. Brand FN, Abbott RD, Kannel WN. Diabetes, intermitent caludication, and the risk of cardiovascular events. Diabetes. 1989;38:504-9.
13. Orchard TJ, Strandness E. Assessment of peripheral vascular disease in diabetes. Report and recomendations of an International Workshop. Circulation. 1993;88:819-28.
14. Becks PJ, Mackaay AJC, Neeling JND, De Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relacion to glycaemic level in an elderly Caucasian population: the Hoorn Study. Diabetologia. 1995;38:86-96.
15. Miettinrn H, Salomaa V. Diabetes and macrovascular disease. J Cardiovascular Risk. 1997;4:76-82.
16. Jude EB, MRCP, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial aisease in diabetic and nondiabetic patients. A comparison of seventy and outcome. Diabetes Care. 2001;24:1433-7.
17. Kallio M, Forsblom C, Groop PH, Groop L, Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care. 2003;26:1241-5.
18. Beach KW, Bedford GR, Bergelin RO, Martin DC, Vandenberghe N, Zaccardi M, et al. Progression of lower-extremity arterial occlusive disease in type II diabetes mellirus. Diabetes Care. 1988;11:464-72.
19. Bundó M, Auba J, Vallés R, Torner O, Pérez AM, Massons J. Arteriopatía periférica en la diabetes mellitus tipo 2. Aten Primaria. 1998;22:5-11.
20. Ogren M, Hedblad B, Isacsson SO, Janzon L, Jungquist G, Lindell SE. Non-invasively detected carotid stenosis and ischemic heart disease in men with leg arteriosclerosis. Lancet. 1993;342:1138-41.
21. Abbot RD, Petrovitch H, Rodríguez BL, Yano K, Schatz IJ, Popper JS, et al. Ankle-brachial blood pressure in men > 70 yeats of age and the risk of coronary Herat disease. Am J Cardiol. 2000;86:280-4.
22. Abbot RD, Rodríguez BL, Petrovitch H, Yano K, Schatz IJ, Popper JS, et al. Ankle-brachial blood pressure in elderly men and the risk of stroke. The Honolulu Heart Program. J Clin Epidemiol. 2001;54:973-8.
23. Zheng ZJ, Sharrett AR, Chambbless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Aterosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131:115-25.
24. Dolan NC, Liu K, Criqui MC, Greenland P, Guralnik JM, Chan Ch, et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002;25:113-20.
25. The Heart Outcomes Prevention Evaluation Study Investigators. Efects of an angiotensin-covertin-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-53.
26. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
27. Adler A, Stevens R, Neil A, Stratton I, Boulton A, Holman R. UKPDS 59: hyperglicemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002;25:894-9.
28. Mehler PS, Coll JR, Estacio R, Esler A, Schier RW, Hiatt WR. Intesive blood control reduces events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107:753-6.
29. Dormandy JA, Rutherford RB. Manegement of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vase Surg. 2000;31:S1-296.
30. The Seventh Report of the Joint National Committee on prevention, evaluation, and treatment of the high blood pressure. JAMA. 2002;289:2560-72.
31. Linton MF, Fazio S; National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP III). A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol. 2003;92:i19-26.
32. Pearson TA. New tools for coronary risk assessnment. What are their advantages and limitations? Circulation. 2002;105:886-92.